Document is current
Any future updates will be listed below
-
Authors
Abdelal, Randa
Raja Banerjee, A.
Carlberg-Racich, Suzanne
Darwaza, Neyla
Ito, Diane https://orcid.org/0000-0003-1396-7395
Shoaff, Jessica
Epstein, Josh
- License Information
-
More Information
Article History
Received: 4 October 2021
Accepted: 7 May 2022
First Online: 20 May 2022
Declarations
:
: This study was approved by the New England Independent Review Board. All participants provided written consent before participating.
: Not applicable.
: Suzanne Carlberg-Racich has received consultancy fees from Hikma Community Health, a Subdivision of Hikma Specialty USA Inc. A. Raja Banerjee, Randa Abdelal and Neyla Darwaza have received stock options exercisable for, and other stock awards of, ordinary shares of Hikma Pharmaceuticals in the course of their employment at Hikma Pharmaceuticals. Diane Ito, Jessica Shoaff and Josh Epstein are employees of Stratevi, a consulting firm that has received research funding from Hikma Community Health, a Subdivision of Hikma Specialty USA Inc., to conduct this study.
